Claudia Wilkin

Claudia Wilkin is an American computational biologist and bioinformatician recognized for her pioneering work in developing algorithms and computational frameworks for analyzing complex biological data, particularly in the fields of single-cell genomics and cancer research. Her research has significantly advanced the understanding of tumor heterogeneity and cell fate determination, providing critical tools for the broader scientific community. Wilkin holds a joint appointment at the Broad Institute and the Massachusetts Institute of Technology, where she leads an interdisciplinary research group.

Early life and education

Born in San Francisco, Wilkin demonstrated an early aptitude for mathematics and the natural sciences. She pursued her undergraduate studies at Stanford University, earning a degree in Computer Science with a minor in Biology, where she was influenced by coursework in machine learning and genetics. For her doctoral research, she attended the California Institute of Technology, completing a PhD in Computational and Systems Biology under the mentorship of renowned scientist Michael B. Eisen. Her thesis focused on novel statistical methods for interpreting DNA microarray data, laying the groundwork for her future career in bioinformatics.

Career

Following her PhD, Wilkin conducted postdoctoral research at the Whitehead Institute in Cambridge, Massachusetts, collaborating with leading figures in genomics like Eric S. Lander. In 2015, she was recruited to establish her independent laboratory at the Broad Institute, with a concurrent appointment as an assistant professor in the Department of Biological Engineering at the Massachusetts Institute of Technology. Her group quickly gained prominence for its collaborative work with experimental labs at Harvard Medical School, the Dana–Farber Cancer Institute, and the Howard Hughes Medical Institute, bridging the gap between data science and wet-lab biology.

Research and contributions

Wilkin's research is centered on creating open-source computational tools to decipher the complexity of biological systems. A major contribution is the development of the "SCALPEL" algorithm suite, a widely adopted framework for processing and analyzing single-cell RNA sequencing data, which has been applied to studies of acute myeloid leukemia and pancreatic cancer. Her team also pioneered methods for integrating multi-omics data, combining epigenomics, proteomics, and spatial transcriptomics to map cellular differentiation trajectories in development and disease. This work has provided key insights into the microenvironment of solid tumors and mechanisms of drug resistance, influencing clinical research strategies at institutions like the Memorial Sloan Kettering Cancer Center.

Awards and honors

Wilkin's innovative work has been recognized with several prestigious awards. She is a recipient of the NIH Director's Pioneer Award, a highly competitive grant from the National Institutes of Health supporting high-risk, high-reward research. Early in her career, she was awarded a Packard Fellowship for Science and Engineering from the David and Lucile Packard Foundation. She has also been honored with the Overton Prize from the International Society for Computational Biology and the Sloan Research Fellowship from the Alfred P. Sloan Foundation. Her research is regularly published in top-tier journals such as *Nature*, *Science*, and *Cell*.

Personal life

Wilkin is an advocate for open science and data sharing, frequently speaking at conferences like the Annual International Conference on Research in Computational Molecular Biology (RECOMB). She serves on the scientific advisory boards for several initiatives, including the Human Cell Atlas project. Outside of her professional life, she is an avid mountaineer and has completed ascents of major peaks in the Andes and the Alaska Range.

Category:American computational biologists Category:American bioinformaticians Category:21st-century American biologists